Restricted accessResearch articleFirst published online 1989-1
Rapid changes in functional responsiveness of the 5-HT system after single-dose and multiple-dose treatment with antidepressants: effects of maprotiline and oxaprotiline and its enantiomers
Functional responsiveness to 5-HTP (L-5-hydroxytryptophan) and quipazine 24 h after one single dose and 24 h and 72 h after repeated administration (2.5 and 10 mg/kg twice daily for 7 days) of maprotiline, oxaprotiline and its (+) and (-) enantiomers was tested in the rat. All compounds markedly increased the behavioural effects of 5-HTP 24 h after one single injection. This effect was further enhanced after repeated treatment. The response to quipazine was less consistently affected than the response to 5-HTP. Neither drug increased the response to quipazine 24 h after the last injection. However, maprotiline and oxaprotiline enhanced the quipazine-induced head-twitch 72 h after the withdrawal of subchronic treat ment, enantiomers failed to do so. This differential effect of drugs in respect to the interactions with 5-HTP and quipazine is, however, not understood at present. The results of this study indicate that only one single dose of antidepressants may change the functional respon siveness of the 5-HT system and that such changes occur rapidly. The results also provide a possible rationale for the suggested antidepressant activity of levoprotiline, the (-) enantiomer of oxaprotiline and otherwise biochemically inactive compound.
Get full access to this article
View all access options for this article.
References
1.
Antelman S.M., DeGiovanni L.A., Kocan D., Perel J.M., Chiodo L.A.1983Amitriptyline sensitization of a serotonin-mediated behavior depends on the passage of time and not repeated treatment. Life Sci33: 1727-1730
2.
Bergstrom D.A.Kellar K.J.1979Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatmentJ Pharmacol Exp Ther209: 256-261
3.
Blackshear M.A., Sanders-Bush E.1982Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J Pharmacol Exp Ther221: 303-308
4.
Delini-Stula A.1984Adaptive Veranderungen der Empfindlichkeit zentraler monoaminerger Systeme nach Behandlung mit Antidepressiva In: Tropfinfusionen in der Depressionsbehandlung , Methoden und Memungen, Internationaler Workshop, Wiesbaden (eds Kielholz P, Adams C), Georg Thieme Verlag, Suttgart, pp 7-16
5.
Delini-Stula A., Radeke E.1985Behavioral and pharmacological characterisation of tryptamine-induced excitation syndrome in rats. In: Neuropsychopharmacology of the trace amines, experimental and clinical aspects (eds Boulton AA, Bieck PR, Maitre L, Reiderer P), Humana Press, Chfton, New Jersey, pp. 125-140
6.
Delini-Stula A., Bischoff S., Radeke E.1982Antiserotoninergic properties of maprotiline and a new antidepressant oxaprotiline: two selective NA-uptake inhibitors DrugDevelop Res2: 543-550
7.
Delini-Stula A., Vassout A., Hauser K., Bittiger H., Buech O., Olpe H-R.1983Oxaprotiline and its enantiomers: do they open new avenues in the research on the mode of action of antidepressants? In: Frontiers in neuropsychiatric research (eds Usdm E, Goldstein M, Fnedhoff A J, Georgotas A), McMillan Press, London, pp. 121-134
8.
De Montigny C., Aghajanian G.K.1978Tricyclic antidepressants. long term treatment increases responsivity of rat forebrain neurones to serotonin. Science202: 1303-1305
9.
Fnedman E., Dallob A.1979Enhanced serotonin receptor activity after chronic treatment with imipramine and amitriptylineComm Psychopharmacol3: 93-99
10.
Fnedman E., Copper T.B., Dallob A.1983Effects of chronic antidepressant treatment on serotonin receptor activity in mice. Eur J Pharmacol8969-76
11.
Fuxe K., Ogren S.O., Agnati L.F., Andersson K., Eneroth P.1982Effects of subchromc antidepressant drug treatment on central serotoninergic mechanisms in the male rat. In: Typical and atypical antidepressants: molecular mechanisms (eds Costa E, Racagm G) Raven Press, New York, pp. 91-107
12.
Green A.R., Heal D.J., Johnson P., Laurence B.E., Nimgaonkar V.L.1983Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine- mediated and dopamine-mediated behaviours and 5-HT2 receptor number in frontal cortex. Br J Pharmacol80: 377-385
13.
Jones R G S1980Enhancement of 5-hydroxytryptamine-induced behavioural effects following chronic administration of antidepressant drugsPsychopharmacology69: 307-311
14.
Katz M.M., Koslow S.H., Maas J.W., Frazer A., Bowden C.L., Casper R., Crouhgan J., Kocsis J., Redmond E. Jr1987The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med17: 297-309
15.
Lucki I., Nobler M.S., Frazer A.1984Differential effects of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. J Pharmacol Exp Ther228: 133-139
16.
Luscombe G., Jenner P., Marsden C.D.1981Pharmacological analysis of the myoclonus induced by 5-hydroxytryptamine in the guinea pig suggests the presence of multiple 5-hydroxytryptamine receptors in the brain. Neuropharmacology20: 819-831
17.
Luscombe G., Jenner P., Marsden C.D.1982Myoclonus in guinea pigs is induced by mdole-contaimng but not piperazine-containing 5-HT agonists. Life Sci30: 1487-1494
18.
Maggi A., U'Prichard D.C., Enna S.J.1980Differential effects of antidepressant treatments on brain monoaminergic receptors. Eur J Pharmacol61. 91-98
19.
Maitre L., Waldmeier P.C., Baumann P.A., Staehelin M.1974: Effect of maprotiline, a new antidepressant drug, on serotonin uptakeAdv Biochem Psychopharmacol10: 297-304
20.
Mc Donald D., Stancel G.M., Enna S.J.1984Binding and function of serotonin receptors following chronic administration of imipramine. Neuropharmacology23/11: 1265-1269
21.
Maj J., Lewandowska A., Rawtow A.1979Central antiserotomn action of amitriptyline. Pharmacopsychiatria12: 281-285
22.
Mogilnicka E., Klimek V.1979Mianserin, danitracen and amitriptyline withdrawal increases the behavioural responses of rats to L-5-HTPJ Pharm Pharmacol31: 704-705
23.
Olpe H.R., Schellenberg A.1981The sensitivity of cortical neurons to serotonin: effect of chronic treatment with antidepressants, serotonin-uptake inhibitors and monoamine-oxidase blocking drugsJ Neural Transm51: 233-244
24.
Ogren S.O., Fuxe K., Agnati L.F., Gustafsson J.A.Jonsson G., Holm A.C.1979Reevaluation of the indoleamine hypothesis of depression: evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs. J Neural Transm46: 85-103
25.
Ortmann R., Waldmeier P.C., Radeke E., Felner A., Delini-Stula A.1980The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats Naunyn-Schmiedeberg'sArch Pharmacol311: 185-192
26.
Pawlowski L., Kwiatek H.1984No correlation exists between antidepressant activity and the ability of 5-HT uptake inhibitors to interact with 5-HT receptors of the rat stomach fundus strip. J Pharm Pharmacol36: 386-390
27.
Pawlowski L., Melzacka M.1986Inhibition of head-twitch response to quipazine in rats by chronic amitriptyline but not nuvoxamme or citalopramPsychopharmacology88: 279-284
Richardson B.P., Engel G.1986The pharmacology and function of 5-HT3 receptors . Trends Neurosci9(9): 424-428
30.
Savage D.D., Mendels J., Frazer A.1980Decrease in 3H-serotonin binding in rat brain produced by the repeated admimstration of either monoamine oxidase inhibition or centrally acting serotonin agonists. Neuropharmacology19: 1063-1070
31.
Schmauss M., Laakmann G., Dieterle D., Schmitz R., Wittman M.1985Clinical investigation on the importance of NEreuptake inhibition for antidepressive efficacy: oxaprotiline versus its Re-enantiomer CGP 12 103A Pharmacopsychiatry18: 86-87
32.
Vetulani J., Lebrecht U., Pilc A.1981Enhancement of responsiveness of the central serotoninergic system and serotomn-2 receptor density in rat frontal cortex by electroconvulsive treatment. Eur J Pharmacol76: 81-85
33.
Vetulam J., Bednarczyk B., Reichenberg K., Rokosz A.1980Head twitches induced by LSD and quipazine. similarities and differencies. Neuropharmacology19: 155-158
34.
Stolz J.F., Marsden C.A., Middlemiss D.N.1983Effect of chromc antidepressant treatment and subsequent withdrawal on 3H-5-hydroxytryptamine and 3H-spiperone binding in rat frontal cortex and serotonin receptor mediated behavior. Psychopharmacology80: 150-155
35.
Waldmeier P.C., Baumann P.A., Wilhelm M., Bernasconi R., Maitre L.1977Selective inhibition of noradrenahne and serotonin uptake by C 49 802-B-Ba and CGP 6085 A. Eur J Pharmacol45: 387-391
36.
Waldmeier P.C., Baumann P.A., Hauser K., Maitre L., Storni A.1982Oxaprotiline, a noradrenaline uptake inhibitor with an active and inactive enantiomer. Biochem Pharmacol31: 2169-2176
37.
Wendt G.1988Levoprotiline—clinical therapeutic efficacy and tolerability. XVIth CINP Congress Munich, 15-19 August 1988, Abstracts, Springer International, p 13
